- Dec 25, 2020
-
ASHP FUROSEMIDE HCl INJECTION SHORTAGE
- Dec 18, 2020
-
Areva Pharmaceuticals Announces Approval of Furosemide Injection USP
- Dec 07, 2020
-
Areva Pharmaceuticals Announces Diversity Certification
- Dec 03, 2020
-
URGENT DRUG RECALL
- May 06, 2020
-
Areva Pharmaceuticals would like to announce the addition of Irinotecan HCL Injection 300mg/15ml to our existing Irinotecan family that includes 40mg/2ml and 100mg/5ml.
- May 06, 2020
-
Areva Pharmaceuticals is excited to announce three new products to our ever-expanding portfolio:
- Mar 06, 2019
-
Areva Pharmaceuticals is excited to announce another addition to our growing product portfolio – Temozolomide (oral capsule)
- Aug 01, 2018
-
Pamidronate Disodium now available.
- Jul 27, 2015
-
Ernst & Young announces Areva Pharmaceuticals Founder & CEO Victor Swaminathan as an EY Entrepreneur Of The Year® 2015 Award finalist in Ohio Valley
- Dec 19, 2014
-
Areva Pharmaceuticals was granted VAWD accreditation by NABP (National Association of Boards of Pharmacy)
- Jul 21, 2014
-
Areva Pharmaceuticals was pleased to announce it was awarded contracts by Amerinet for Irinotecan and Pamidronate.
- May 16, 2014
-
Areva Pharmaceuticals owners and community leaders were joined by residents of the Lanesville Indiana and outlying communities for a ribbon cutting ceremony and open house.
- May 03, 2013
-
Areva Pharmaceuticals was awarded a contract with Apexus for Epirubicin, Irinotecan, and Pamidronate.
- Mar 05, 2013
-
Local Community Rolls Out Red Carpet for Areva
- Oct 21, 2010
-
Areva receives FDA approval for Pamidronate Disodium Injection 3 mg/ml and 9 mg/ml
Areva Gallery
